CAPTRUST FINANCIAL ADVISORS - CALYPTE BIOMEDICAL CORP ownership

Back to all holdings Add to watchlist

CALYPTE BIOMEDICAL CORP's ticker is CBMC and the CUSIP is 131722605. A total of 2 filers reported holding CALYPTE BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of CALYPTE BIOMEDICAL CORP
ValueSharesWeighting
Q1 2022$0–330.0%0.00%–
Q2 2018$0–330.0%0.00%–
Q1 2018$0–33–0.00%–
 Download
Other shareholders

There were no reported owners of CALYPTE BIOMEDICAL CORP in Q1 2022.

NameSharesValueWeighting ↓
View complete list of CALYPTE BIOMEDICAL CORP shareholders